Welcome to our dedicated page for AllianzIM U.S. Large Cap Buffer10 Feb ETF news (Ticker: FEBT), a resource for investors and traders seeking the latest updates and insights on AllianzIM U.S. Large Cap Buffer10 Feb ETF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AllianzIM U.S. Large Cap Buffer10 Feb ETF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AllianzIM U.S. Large Cap Buffer10 Feb ETF's position in the market.
Allianz Investment Management has launched a February series of U.S. Large Cap Buffered ETFs, which includes the AllianzIM U.S. Large Cap Buffer10 Feb ETF (NYSE Arca: FEBT) and the AllianzIM U.S. Large Cap Buffer20 Feb ETF (NYSE Arca: FEBW). These ETFs provide downside buffers of 10% and 20% against market declines while allowing for participation in the upside potential of the SPDR S&P 500 ETF Trust. The series is designed for investors seeking risk mitigation amidst market volatility, with a 12-month Outcome Period from February 1, 2023, to January 31, 2024. The expense ratio is 0.74%, and AllianzIM's assets under management amount to $17.5 billion.
FAQ
What is the current stock price of AllianzIM U.S. Large Cap Buffer10 Feb ETF (FEBT)?
